Merck & Co., Inc. (branded as MSD outside the United States and Canada) is a global biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of human prescription medicines, vaccines, and biologic therapies. The company’s portfolio and pipeline span major therapeutic areas including oncology, infectious diseases, vaccines, cardiometabolic conditions, and immunology.
Merck also operates a substantial animal health business (Merck Animal Health/MSD Animal Health), providing veterinary pharmaceuticals, vaccines, and health management solutions for companion and production animals. The company maintains a worldwide network of research, clinical development, and manufacturing sites supporting small-molecule, biologics, and vaccine production.
Note: Merck & Co., Inc. (MSD) is distinct from Merck KGaA, Darmstadt, Germany, which operates separately and uses different branding in North America.
Official website: merck-animal-health.com
chemXplore is tracking 5 active investment projects involving Merck — 3 new-build and 2 expansion, across sectors such as Basic Chemicals, Biobased & Circular, and Polymers.
Merck's role is mapped on each — as Owner.
To provide comprehensive coverage, we aggregate data and news under the name Merck, encompassing the following company names, divisions, and related entities:
MSD, Merck Sharp & Dohme, MSD Animal Health, Merck & Co., Inc., Merck Animal Health, Merck Sharp & Dohme Corp., and Merck Research Laboratories.
This list encompasses current and former names, alternate names, and key divisions associated with Merck, ensuring you can easily find all relevant information under a single, unified profile.
